BridgeBio Pharma
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $222,440 | $194,515 | $154,180 | $120,700 |
Gross Profit | 207,394 | 184,090 | 138,762 | 114,137 |
EBITDA | -136,629 | -112,554 | -180,238 | -173,345 |
EBIT | -142,613 | -113,740 | -185,238 | -174,743 |
Net Income | -152,216 | -164,043 | -197,238 | -182,743 |
Net Change In Cash | 222,440 | 194,515 | 154,180 | 120,700 |
Free Cash Flow | -223,776 | -197,348 | -60,953 | -110,044 |
Cash | 677,911 | 879,891 | 570,119 | 642,951 |
Basic Shares | 195,785 | 194,789 | 197,238 | 190,517 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $502,078 | $221,902 | $9,303 | $77,648 |
Gross Profit | 473,805 | 218,024 | 6,857 | 74,214 |
EBITDA | -672,884 | -436,829 | -565,468 | -397,443 |
EBIT | -681,883 | -442,904 | -571,962 | -404,214 |
Net Income | -729,306 | -535,762 | -643,202 | -481,183 |
Net Change In Cash | 502,078 | 221,902 | 9,303 | 77,648 |
Cost of Revenue | 20,519 | |||
Free Cash Flow | -447,007 | -521,659 | -529,026 | -425,815 |
Cash | 570,119 | 681,101 | 375,935 | 376,689 |
Basic Shares | 197,238 | 186,076 | 162,791 | 147,473 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.78 |
2026-03-31 | -$0.84 |
2025-12-31 | -$0.93 |
2025-09-30 | -$0.72 |